Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022

Ulrich Kohnert, Manfred Wozny, Manuel Llinas, Anita Roos, Stephan Fischer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BM 06.022 is a tissue-type plasminogen activator deletion variant that is comprised of the kringle 2 and the protease domain of the native molecule. BM 06.022 is expressed as inactive inclusion bodies in E. coli and transferred into the active enzyme by an in vitro folding process. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone provides evidence that the purified BM 06.022 is fully active and that misfolded species are completely removed by affinity chromatography on ETI-Sepharose. The comparison of the kinetics of the inhibition of BM 06.022 with that of CHO-t-PA indicates that the active centers of both enzymes are rather similar. The further evaluation of the site of interaction of BM 06.022 and DnsEGRck by mass spectroscopy and amino acid sequence analysis revealed that the inhibitor is bound selectively to His322, which is part of the catalytic triad of this serine protease.

Original languageEnglish (US)
Pages (from-to)157-166
Number of pages10
JournalApplied Biochemistry and Biotechnology
Volume55
Issue number2
DOIs
StatePublished - Nov 1 1995

Fingerprint

Tissue Plasminogen Activator
Ketones
Labeling
Catalytic Domain
Enzymes
Tissue
Affinity chromatography
Escherichia coli
Amino acids
Spectroscopy
Molecules
Kinetics
Kringles
Inclusion Bodies
Protein Sequence Analysis
Serine Proteases
Affinity Chromatography
Sepharose
Mass Spectrometry
Peptide Hydrolases

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Biochemistry
  • Applied Microbiology and Biotechnology
  • Molecular Biology

Cite this

@article{d10d160d00fb438b850a60c8d35361f0,
title = "Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022",
abstract = "BM 06.022 is a tissue-type plasminogen activator deletion variant that is comprised of the kringle 2 and the protease domain of the native molecule. BM 06.022 is expressed as inactive inclusion bodies in E. coli and transferred into the active enzyme by an in vitro folding process. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone provides evidence that the purified BM 06.022 is fully active and that misfolded species are completely removed by affinity chromatography on ETI-Sepharose. The comparison of the kinetics of the inhibition of BM 06.022 with that of CHO-t-PA indicates that the active centers of both enzymes are rather similar. The further evaluation of the site of interaction of BM 06.022 and DnsEGRck by mass spectroscopy and amino acid sequence analysis revealed that the inhibitor is bound selectively to His322, which is part of the catalytic triad of this serine protease.",
author = "Ulrich Kohnert and Manfred Wozny and Manuel Llinas and Anita Roos and Stephan Fischer",
year = "1995",
month = "11",
day = "1",
doi = "10.1007/BF02783556",
language = "English (US)",
volume = "55",
pages = "157--166",
journal = "Applied Biochemistry and Biotechnology",
issn = "0273-2289",
publisher = "Humana Press",
number = "2",

}

Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022. / Kohnert, Ulrich; Wozny, Manfred; Llinas, Manuel; Roos, Anita; Fischer, Stephan.

In: Applied Biochemistry and Biotechnology, Vol. 55, No. 2, 01.11.1995, p. 157-166.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022

AU - Kohnert, Ulrich

AU - Wozny, Manfred

AU - Llinas, Manuel

AU - Roos, Anita

AU - Fischer, Stephan

PY - 1995/11/1

Y1 - 1995/11/1

N2 - BM 06.022 is a tissue-type plasminogen activator deletion variant that is comprised of the kringle 2 and the protease domain of the native molecule. BM 06.022 is expressed as inactive inclusion bodies in E. coli and transferred into the active enzyme by an in vitro folding process. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone provides evidence that the purified BM 06.022 is fully active and that misfolded species are completely removed by affinity chromatography on ETI-Sepharose. The comparison of the kinetics of the inhibition of BM 06.022 with that of CHO-t-PA indicates that the active centers of both enzymes are rather similar. The further evaluation of the site of interaction of BM 06.022 and DnsEGRck by mass spectroscopy and amino acid sequence analysis revealed that the inhibitor is bound selectively to His322, which is part of the catalytic triad of this serine protease.

AB - BM 06.022 is a tissue-type plasminogen activator deletion variant that is comprised of the kringle 2 and the protease domain of the native molecule. BM 06.022 is expressed as inactive inclusion bodies in E. coli and transferred into the active enzyme by an in vitro folding process. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone provides evidence that the purified BM 06.022 is fully active and that misfolded species are completely removed by affinity chromatography on ETI-Sepharose. The comparison of the kinetics of the inhibition of BM 06.022 with that of CHO-t-PA indicates that the active centers of both enzymes are rather similar. The further evaluation of the site of interaction of BM 06.022 and DnsEGRck by mass spectroscopy and amino acid sequence analysis revealed that the inhibitor is bound selectively to His322, which is part of the catalytic triad of this serine protease.

UR - http://www.scopus.com/inward/record.url?scp=0029399751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029399751&partnerID=8YFLogxK

U2 - 10.1007/BF02783556

DO - 10.1007/BF02783556

M3 - Article

C2 - 7495332

AN - SCOPUS:0029399751

VL - 55

SP - 157

EP - 166

JO - Applied Biochemistry and Biotechnology

JF - Applied Biochemistry and Biotechnology

SN - 0273-2289

IS - 2

ER -